Gene Therapy with Interferon Alpha and the Angiogenic Inhibitor, Vasostatin, in Neuroendocrine Tumors of the Digestive System

IFN-α has been applied in medical treatment of various neuroendocrine (NE) tumors, either alone or combination with somatostatin analogues. They can improve clinical symptoms in 50-70% of patients but a significant tumor reduction is only observed in 5-15% patients. Vasostatin (vaso) is believed to...

Full description

Bibliographic Details
Main Author: Liu, Minghui
Format: Doctoral Thesis
Language:English
Published: Uppsala universitet, Institutionen för medicinska vetenskaper 2007
Subjects:
Online Access:http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-7453
http://nbn-resolving.de/urn:isbn:978-91-554-6784-5